MARKET

ANGO

ANGO

AngioDynamics
NASDAQ

Real-time Quotes | Nasdaq Last Sale

15.17
+1.03
+7.28%
Opening 15:01 12/04 EST
OPEN
14.22
PREV CLOSE
14.14
HIGH
15.56
LOW
14.17
VOLUME
412.93K
TURNOVER
--
52 WEEK HIGH
17.24
52 WEEK LOW
7.48
MARKET CAP
575.75M
P/E (TTM)
-3.4017
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Angiodynamics In Shares Up 48.1% Since SmarTrend's Buy Recommendation (ANGO)
SmarTrend identified an Uptrend for Angiodynamics In (NASDAQ:ANGO) on September 21st, 2020 at $9.71. In approximately 2 months, Angiodynamics In has returned 48.09% as of today's recent price of $14.38.
Comtex SmarTrend(R) · 11/27 05:23
Cooper Companies (COO) to Post Q4 Earnings: What's in Store?
Cooper Companies' (COO) fiscal fourth-quarter performance is likely to reflect better performance by CVI and CSI.
Zacks · 11/26 13:58
AngioDynamics rallies; Raymond James upgrades on high risk/reward
Raymond James analyst Jayson Bedford upgraded AngioDynamics ([[ANGO]] +10.8%) to Strong Buy from Market Perform; PT, $18.Analyst says the company offers the most compelling risk/reward in his small cap medical technology
Seekingalpha · 11/25 16:25
What's in Store for Patterson Companies' (PDCO) Q2 Earnings?
Patterson Companies' (PDCO) fiscal second-quarter results are likely to reflect improvement at Dental segment.
Zacks · 11/25 12:47
Veeva Systems (VEEV) to Post Q3 Earnings: What's in Store?
Veeva Systems' (VEEV) fiscal third-quarter results are likely to reflect solid show by its segments and robust product portfolio.
Zacks · 11/25 12:44
Raymond James Upgrades AngioDynamics to Strong Buy, Announces $18 Price Target
Raymond James upgrades AngioDynamics (NASDAQ:ANGO) from Market Perform to Strong Buy and announces $18 price target.
Benzinga · 11/25 12:11
Shares of ANGO Up 24.1% Since Uptrend Call on Shares
SmarTrend identified an Uptrend for Angiodynamics In (NASDAQ:ANGO) on September 21st, 2020 at $9.71. In approximately 2 months, Angiodynamics In has returned 24.10% as of today's recent price of $12.05.
Comtex SmarTrend(R) · 11/19 17:55
AngioDynamics (ANGO) Shows Solid Results from RAPID Database
Zacks · 11/17 13:48
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of ANGO. Analyze the recent business situations of AngioDynamics through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 3 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average ANGO stock price target is 16.00 with a high estimate of 18.00 and a low estimate of 14.00.
EPS
Institutional Holdings
Institutions: 254
Institutional Holdings: 38.88M
% Owned: 102.46%
Shares Outstanding: 37.95M
TypeInstitutionsShares
Increased
51
2.10M
New
39
-281.87K
Decreased
43
2.37M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
+1.26%
Healthcare Equipment & Supplies
+1.05%
Key Executives
Chairman/Independent Director
Howard Donnelly
President/Chief Executive Officer/Director
James Clemmer
Chief Financial Officer/Executive Vice President/IR Contact Officer
Stephen Trowbridge
Senior Vice President/General Manager
Brent Boucher
Senior Vice President/General Manager
Chad Campbell
Senior Vice President/General Manager
Scott Centea
Senior Vice President/Director of Human Resources
Marna Bronfen-Moore
Senior Vice President
Benjamin Davis
Senior Vice President
David Helsel
Senior Vice President
Warren Nighan
Senior Vice President
Kim Seabury
Independent Director
Eileen Auen
Independent Director
Wesley Johnson
Independent Director
Karen Licitra
Independent Director
Dennis Meteny
Independent Director
Jan Reed
Independent Director
Michael Tarnoff
  • Dividends
  • Splits
  • Insider Activity
No Data
  • All
  • Financials
  • Insiders
More
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About ANGO
AngioDynamics, Inc. designs, manufactures and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. The Company's devices are used in minimally invasive, image-guided procedures. The Company offers products within three product groupings: Vascular Interventions & Therapies, Vascular Access and Oncology. The Company's Vascular Interventions & Therapies products include Venous, Thrombus Management, as well as other core products. The Company's BioFlo products incorporate Endexo Technology into the manufacturing and design of its Vascular Access products. Its Oncology product offerings include its Microwave Ablation products, Radiofrequency Ablation (RFA) and its NanoKnife product lines. Through its subsidiary, Eximo Medical, Ltd., the Company operates 355 nanometers (nm) wavelength laser-technology platform.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of AngioDynamics, Inc. stock information, including NASDAQ:ANGO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ANGO stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ANGO stock methods without spending real money on the virtual paper trading platform.